Silvia Pelligra

Clinical outcome of recurrent endometrial cancer: analysis of post-relapse survival by pattern of recurrence and secondary treatment

Francesco Legge, Stefano Restaino, Luca Leone et al. · International Journal of Gynecological Cancer · 2019 · 94 citations

Medicine, Gynecology, Oncology +16

Robotic versus laparoscopic radical hysterectomy in early cervical cancer: A case matched control study

Valerio Gallotta, Carmine Conte, Alex Federico et al. · European Journal of Surgical Oncology · 2018 · 74 citations

Medicine, Gynecology, Surgery +15

Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer

Emanuele Perrone, Salvatore Lopez, Burak Zeybek et al. · Frontiers in Oncology · 2020 · 63 citations · Full text

Medicine, Oncology, Pharmacology +17

DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo

Joan Tymon‐Rosario, Elena Bonazzoli, Stefania Bellone et al. · Gynecologic Oncology · 2021 · 18 citations · Full text

Medicine, Oncology, Pharmacology +12

Further refining 2020 <scp>ESGO</scp>/<scp>ESTRO</scp>/<scp>ESP</scp> molecular risk classes in patients with early‐stage endometrial cancer: A propensity score–matched analysis

Camilla Nero, Tina Pasciuto, Serena Cappuccio et al. · Cancer · 2022 · 14 citations · Full text

Medicine, Oncology, Pathology +17